The U.S. Food and Drug Administration (FDA) has an entry for application number ANDA080493. The application pertains to an oral tablet formulation of CORTISONE ACETATE, 25 mg per tablet, submitted by Purepac Pharm.
According to the FDA data, the product (product number 001) is listed as discontinued, is not a reference drug, and has no reference standard indicated.
法规动态2026年9月16日•3 分钟阅读
FDA Lists ANDA080493 for Purepac CORTISONE ACETATE Oral Tablet (Discontinued)
The FDA entry ANDA080493 shows Purepac Pharm's oral CORTISONE ACETATE 25 mg tablet is listed as discontinued.
由 Pharmacountry 团队整理 · 来源： FDA.gov
主题：
评分
(0)
(0)
(0)
(0)
(0)
留下您的评分